Icad Financials
ICAD Stock | USD 1.42 0.09 5.96% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 2.78 | 4.398 |
|
|
The financial analysis of Icad is a critical element in measuring its lifeblood. Investors should not minimize Icad's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Icad | Select Account or Indicator |
Understanding current and past Icad Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Icad's financial statements are interrelated, with each one affecting the others. For example, an increase in Icad's assets may result in an increase in income on the income statement.
Please note, the presentation of Icad's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Icad's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Icad's management manipulating its earnings.
Icad Stock Summary
Icad competes with Profound Medical, Si Bone, Sight Sciences, Nevro Corp, and Paragon 28. iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US44934S2068 |
CUSIP | 44934S206 44934S107 443209101 |
Location | New Hampshire; U.S.A |
Business Address | 98 Spit Brook |
Sector | Health Care Technology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.icadmed.com |
Phone | 603 882 5200 |
Currency | USD - US Dollar |
Icad Key Financial Ratios
There are many critical financial ratios that Icad's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that icad inc reports annually and quarterly.Return On Equity | -0.15 | ||||
Profit Margin | (0.12) % | ||||
Operating Margin | (0.39) % | ||||
Price To Sales | 2.12 X | ||||
Revenue | 17.32 M |
Icad Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 41.7M | 55.6M | 62.2M | 51.7M | 41.4M | 43.2M | |
Other Current Liab | 6.6M | 7.0M | 5.6M | 4.7M | 2.4M | 3.2M | |
Net Debt | 7.2M | (18.4M) | (33.1M) | (17.9M) | (21.2M) | (20.1M) | |
Retained Earnings | (224.3M) | (241.9M) | (253.2M) | (266.8M) | (271.7M) | (258.1M) | |
Cash | 15.3M | 27.2M | 34.3M | 21.3M | 21.7M | 22.8M | |
Net Receivables | 9.8M | 10.0M | 8.9M | 8.9M | 6.4M | 5.7M | |
Inventory | 2.6M | 3.1M | 4.2M | 5.4M | 917K | 871.2K | |
Other Current Assets | 1.5M | 1.9M | 3.0M | 2.6M | 699K | 681.0K | |
Total Liab | 36.7M | 25.1M | 15.7M | 16.8M | 8.0M | 14.5M | |
Total Current Assets | 29.2M | 42.3M | 50.3M | 38.2M | 29.7M | 19.9M | |
Intangible Assets | 1.2M | 889K | 683K | 482K | 148K | 140.6K | |
Short Term Debt | 5.0M | 726K | 889K | 582K | 188K | 178.6K | |
Accounts Payable | 2.0M | 2.9M | 2.8M | 2.0M | 712K | 676.4K | |
Common Stock | 196K | 236K | 253K | 254K | 265K | 215.4K | |
Other Assets | 50K | 3.3M | 899K | 185K | 1.0 | 0.95 | |
Long Term Debt | 5.1M | 4.3M | 2.0M | 7.0M | 8.0M | 4.3M | |
Other Liab | 361K | 359K | 271K | 446K | 401.4K | 381.3K | |
Net Tangible Assets | (4.5M) | 21.3M | 37.5M | 26.1M | 23.5M | 16.2M | |
Capital Surpluse | 217.4M | 218.9M | 230.6M | 300.9M | 346.0M | 236.9M |
Icad Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 784K | 476K | 141K | 10K | 16K | 15.2K | |
Total Revenue | 31.3M | 29.7M | 33.6M | 27.9M | 17.3M | 23.3M | |
Gross Profit | 24.2M | 21.4M | 24.2M | 19.8M | 14.5M | 15.1M | |
Operating Income | (6.4M) | (9.4M) | (10.7M) | (13.9M) | (7.7M) | (8.1M) | |
Ebit | (6.4M) | (16.8M) | (10.7M) | (13.8M) | (7.7M) | (7.3M) | |
Ebitda | (12.1M) | (16.2M) | (10.2M) | (13.2M) | (7.3M) | (6.9M) | |
Cost Of Revenue | 7.1M | 8.3M | 9.4M | 8.1M | 2.8M | 2.6M | |
Income Before Tax | (13.5M) | (17.6M) | (11.2M) | (13.8M) | (7.0M) | (7.3M) | |
Net Income | (13.6M) | (17.6M) | (11.2M) | (13.7M) | (7.4M) | (7.8M) | |
Research Development | 9.3M | 8.1M | 9.2M | 8.6M | 5.2M | 6.2M | |
Tax Provision | 43K | 38K | 1K | (116K) | (103K) | (97.9K) | |
Interest Income | 344K | 97K | 15K | 213K | 652K | 684.6K | |
Net Interest Income | (440K) | (476K) | (141K) | 203K | 647K | 679.4K |
Icad Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 3.1M | 11.9M | 7.1M | (13.0M) | 357K | 682.7K | |
Free Cash Flow | (7.4M) | (7.5M) | (10.0M) | (13.3M) | (6.2M) | (5.9M) | |
Depreciation | 674K | 577K | 557K | 521K | 409K | 388.6K | |
Other Non Cash Items | 6.9M | 8.0M | 667K | 1.5M | 209K | 191.5K | |
Capital Expenditures | 316K | 306K | 474K | 587K | 534K | 1.3M | |
Net Income | (13.6M) | (17.6M) | (11.2M) | (13.7M) | (7.0M) | (7.4M) | |
End Period Cash Flow | 15.3M | 27.2M | 34.3M | 21.3M | 21.7M | 22.8M | |
Change To Inventory | (1.0M) | (533K) | (1.0M) | (1.2M) | 1.5M | 1.6M | |
Change To Netincome | 5.2M | 6.4M | 10.7M | 3.4M | 3.1M | 2.9M | |
Net Borrowings | (13K) | (16K) | 319K | (7.4M) | (6.6M) | (6.3M) | |
Investments | (306K) | (474K) | (587K) | (534K) | (844K) | (801.8K) |
Icad Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Icad's current stock value. Our valuation model uses many indicators to compare Icad value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icad competition to find correlations between indicators driving Icad's intrinsic value. More Info.icad inc is rated third overall in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . At present, Icad's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Icad by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.icad inc Systematic Risk
Icad's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Icad volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty-two with a total number of output elements of nine. The Beta measures systematic risk based on how returns on icad inc correlated with the market. If Beta is less than 0 Icad generally moves in the opposite direction as compared to the market. If Icad Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one icad inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Icad is generally in the same direction as the market. If Beta > 1 Icad moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Icad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Icad's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Icad growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Icad September 7, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Icad help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of icad inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of icad inc based on widely used predictive technical indicators. In general, we focus on analyzing Icad Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Icad's daily price indicators and compare them against related drivers.
Information Ratio | (0.04) | |||
Maximum Drawdown | 18.63 | |||
Value At Risk | (5.75) | |||
Potential Upside | 6.25 |
Complementary Tools for Icad Stock analysis
When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |